Patients from 105+ countries have trusted us
Join hundreds of happy patients who choose the right treatment and care.
Get A Quote
Acute Myeloid Leukemia
- Days In Hospital 7 days
- Outside Hospital Stay 30 days
- Success Rate 75%
Minimum Cost
$ 8000
Maximum Cost.
$ 13000
Most Asked Procedures
Overview of Acute Myeloid Leukemia in India
The cancer known as acute myeloid leukaemia develops in the bone marrow, the soft centre of the bone. This cancer spreads quickly and has the potential to spread to other parts of the body, including the brain, testicles, and blood. The majority of cells in this kind of cancer are immature. As a result, these cells develop abnormalities and lose their capacity to carry out the body's regular tasks.
Cell function is impacted by genetic alterations that occur in acute myeloid leukaemia. The condition is extremely complicated and needs to be treated aggressively. In addition to preventing the generation of healthy cells, these aberrant cancer cells also consume more nutrients than healthy cells, which makes it impossible for healthy cells to endure for an extended period of time.
This may cause the patient's condition to worsen even more. It is challenging to diagnose acute myeloid leukaemia based solely on symptoms in its early stages, when it exhibits flu-like symptoms. Because acute myeloid leukaemia can significantly impair a patient's quality of life once it develops, some risk factors should be avoided.
Some individuals with risk factors do not acquire acute myeloid leukaemia, and in other situations, the disease develops without any risk factors. Because of this, it is still unclear what specifically causes genetic mutation.
In India, the price range for AML treatment is between 8,000 and 13,000 USD. Depending on the sort of treatment each patient receives, the price may change. Each patient's difficulties and the necessity of supportive care in addition to acute myeloid leukaemia treatment might further affect the cost.
What Is Acute Myeloid Leukemia (Aml)?
The rare illness known as acute myeloid leukaemia (AML) affects both your blood and bone marrow. Usually, it occurs when specific genes or chromosomes undergo mutations. AML mostly affects adults 60 years of age and older, however it can also strike youngsters and younger adults. The aggressive cancer known as acute myeloid leukaemia has the potential to be fatal. With AML, people are living longer thanks to newer treatments.
About 4 out of every 100,000 persons are affected by acute myeloid leukaemia each year. Approximately 1,160 children are diagnosed with AML annually.
Types of Acute Myeloid Leukemia:
AML is divided into various subtypes. Although all of them have an impact on your blood cell counts, different forms of AML have distinct symptoms and react differently to therapy.
By looking at malignant cells under a microscope, medical pathologists can identify AML subtypes. They also check for chromosome abnormalities and gene mutations that affect how cells develop and work.
AML subtypes consist of:
Myeloid leukemia: Myeloid leukaemia is a type of cancer that affects cells that make the white blood cell neutrophil. The myeloid leukaemia subtype is present in the majority of AML patients.
Acute monocytic leukemia (AML-M5): Cancer of the cells that make the white blood cell monocytes is known as acute monocytic leukaemia (AML-M5).
Acute megakaryocytic leukemia (AMLK): Cancer in cells that make platelets or red blood cells is known as acute megakaryocytic leukaemia (AMLK).
Acute promyelocytic leukemia (APL): Acute promyelocytic leukaemia (APL) is a type of cancer that prevents the development of promyelocytes, or immature white blood cells.
Procedure:
Chemotherapy
The most popular treatment for malignancies of all kinds is chemotherapy. Drugs used in chemotherapy stop the growth of cancer cells, thus killing them. Both oral and injectable forms of these drugs are available to the patient.
Targeted Therapy
Drugs that target and destroy particular proteins found in cancer cells are used in target therapy. By focussing on the molecules of cancer cells, these medications are also utilised to treat acute myeloid leukaemia.
Stem Cell Transplantation
This kind of treatment involves the replacement of damaged stem cells with new, healthy stem cells that encourage the body to produce new blood cells. Younger patients are frequently treated with this medication.
Radiation Therapy
High-energy rays are used in radiation therapy to target and kill cancer cells. It may be used in certain cases when leukaemia cells have moved to other parts of the body, however it is less frequently used in AML.
Supportive Care
Adverse side effects are possible with the medications used to treat acute myeloid leukaemia. In this situation, supportive care is necessary, and the patient is often treated holistically with blood transfusions, infection-treating medications, and symptom-management medications.
Best Doctors in India
Cost of Acute Myeloid Leukemia in India
The total cost of AML therapy in India can be influenced by a number of factors. The following variables impact the cost of AML therapy in India:
Complexity of Disease
Gene mutations and AML stages
Reaction to the first treatments
Treatment Approach
intensity of chemotherapy
Needs for stem cell transplants
Other forms of help
Hospital and Physician Selection
The standing of a healthcare facility
Advanced treatment technology and specialised oncology skills
Patient-Specific Factors
Age and general state of health
Medical disorders that coexist
Supportive care is necessary.
Recognise Your Treat
Top Hospitals in India
Indications of Acute Myeloid Leukemia:
Those who have acute myeloid leukaemia may have:
A fever
Bruising, gum bleeding, nose bleeding, and blood in the urine or stool are examples of bleeding symptoms.
Low haemoglobin fatigue or anaemia
Loss of appetite or weight
Skin patches that are tiny and red (petechiae)
Gum swelling
Splenic or liver infections that are enlarged
Breathlessness and skeletal discomfort
Risk Factors:
Acute myeloid leukaemia can occur in certain individuals with myeloproliferative neoplasms (myeloproliferative diseases). Myelo refers to bone marrow. It indicates too many to be proliferative.) ML can also develop in people who have the following disorders:
Vera polycythaemia.
myelofibrosis.
thrombocytosis.
syndrome of myelodysplastics.
aplastic anaemia.
Risk Factors of Acute Myeloid Leukemia
The following are some factors that may raise the chance of getting acute myelogenous leukaemia (AML):
Growing older: Adults 65 and older are more likely to develop AML, and this risk rises with age.
Sex: Compared to women, men are more likely to display this syndrome.
Prior cancer treatment: Individuals who have previously had specific forms of radiation and chemotherapy are more likely to develop AML in the future.
Radiation exposure: Individuals who are regularly exposed to extremely high radiation levels are also more likely to develop AML.
Exposure to dangerous chemicals: Patients are at a higher risk of acquiring AML gradually after being exposed to specific chemicals, such as benzene.
smoking.
Other blood disorders: AML is more likely to develop in those who have myelodysplasia, myelofibrosis, polycythaemia vera, or thrombocythemia.
Genetic illnesses. AML risk may be increased by some genetic conditions, such as Down syndrome.
Frequently Asked Questions (FAQ’s)
There live the blind texts separated they right at the coast of the Semantics.
Adults with AML have a 5-year survival rate of about 29.5%. This indicates that after five years, about 29.5 out of 100 persons with an AML diagnosis are still living.
It is possible to cure acute myeloid leukaemia (AML), particularly with prompt and efficient treatment. Improvements in treatment have greatly increased survival and cure rates, while the likelihood of recovery varies based on variables such as the individual's general health and the type of AML.
Indeed, a large number of persons with acute myeloid leukaemia (AML) survive, and as therapy has advanced, so too have the odds of survival. Five years after diagnosis, 30% of adults with AML are still living, and some go on to have a full recovery or a long-term remission.
The most common cause of mortality in Acute Myeloid Leukaemia (AML) is complications from the illness or its treatment. These include organ failure, haemorrhage, and serious infections.